MAPT and Alzheimer disease: High specificity (the ΔI of tau protein > 12% while ΔI < 4% in Aβ, HSA, GLU, or AA) was shown by the sensor, with a Kd of 7.6 pM in human serum and stability of up to two weeks, ensuring robustness for early-stage AD diagnosis.